UCNP-based Photoluminescent Nanomedicines for Theranostics of HER2-positive tumors

被引：0
|
作者：
Guryev, Evgenii L. [1 ]
Bausheva, Daria K. [1 ]
Shilyagina, Natalia Y. [1 ]
Balalaeva, Irina V. [1 ]
Deyev, Sergey M. [2 ,3 ]
Zvyagin, Andrei V. [1 ,3 ,4 ]
机构：
[1] Lobachevsky State Univ Nizhny Novgorod, Nizhnii Novgorod, Russia
[2] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia
[3] Sechenov Univ, Inst Mol Theranost, Moscow, Russia
[4] Macquarie Univ, MQ Photon Ctr, Sydney, NSW, Australia
来源：
CELL DEATH DISCOVERY | 2022年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [1] UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer
    Guryev, Evgenii L.
    Smyshlyaeva, Anita S.
    Shilyagina, Natalia Y.
    Sokolova, Evgeniya A.
    Shanwar, Samah
    Kostyuk, Alexey B.
    Lyubeshkin, Alexander V.
    Schulga, Alexey A.
    Konovalova, Elena V.
    Lin, Quan
    Roy, Indrajit
    Balalaeva, Irina V.
    Deyev, Sergey M.
    Zvyagin, Andrei V.
    [J]. MOLECULES, 2020, 25 (18):
  • [2] Multifunctional Complexes Based on Photoluminescent Upconversion Nanoparticles for Theranostics of the HER2-Positive Tumors
    Guryev, E. L.
    Smyshlyaeva, A. S.
    Shilyagina, N. Yu.
    Shanwar, S.
    Kostyuk, A. B.
    Shulga, A. A.
    Konovalova, E. V.
    Zvyagin, A. V.
    Deyev, S. M.
    Petrov, R. V.
    [J]. DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2020, 491 (01) : 73 - 76
  • [3] Multifunctional Complexes Based on Photoluminescent Upconversion Nanoparticles for Theranostics of the HER2-Positive Tumors
    E. L. Guryev
    A. S. Smyshlyaeva
    N. Yu. Shilyagina
    S. Shanwar
    A. B. Kostyuk
    A. A. Shulga
    E. V. Konovalova
    A. V. Zvyagin
    S. M. Deyev
    R. V. Petrov
    [J]. Doklady Biochemistry and Biophysics, 2020, 491 : 73 - 76
  • [4] Plasmonic silver nanoparticles for theranostics of HER2-positive cancer
    Shipunova, V. O.
    Belova, M. M.
    Kotelnikova, P. A.
    Deyev, S. M.
    [J]. INTERNATIONAL CONFERENCE LASER OPTICS 2020 (ICLO 2020), 2020,
  • [5] All HER2-Positive Tumors are not Created Equal
    Elizabeth A. Mittendorf
    Mariana Chavez-MacGregor
    [J]. Annals of Surgical Oncology, 2017, 24 : 3471 - 3474
  • [6] All HER2-Positive Tumors are not Created Equal
    Mittendorf, Elizabeth A.
    Chavez-MacGregor, Mariana
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3471 - 3474
  • [7] New ADC Shrinks HER2-Positive Tumors
    Leslie, Mitch
    [J]. CANCER DISCOVERY, 2019, 9 (09) : 1151 - 1152
  • [8] A new strategy to ERADicate HER2-positive breast tumors?
    Arora, Sanjeevani
    Golemis, Erica A.
    [J]. SCIENCE SIGNALING, 2015, 8 (378)
  • [9] Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
    Ardeshirpour, Yasaman
    Sackett, Dan L.
    Knutson, Jay R.
    Gandjbakhche, Amir H.
    [J]. EJNMMI RESEARCH, 2018, 8
  • [10] Using in vivo fluorescence lifetime imaging to detect HER2-positive tumors
    Yasaman Ardeshirpour
    Dan L. Sackett
    Jay R. Knutson
    Amir H. Gandjbakhche
    [J]. EJNMMI Research, 8
12345